Astellas Pharma Acquires IVERIC bio
Astellas Pharma acquired IVERIC bio for $5.9B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Astellas Pharma
- Acquired Company
- IVERIC bio
- Price
- $5.9B
- Acquisition Type
- Acquisition
- Announced
- April 30, 2023
Canonical: https://fsome.com/acquisitions/astellas-pharma-acquires-iveric-bio-8165918 · For the full deal terms, timeline, and press references, please enable JavaScript.